Item 2.02 Results of Operations and Financial Condition.

On August 4, 2022, Organon & Co. (the "Company") issued a press release (the "Earnings Release") regarding its results for the quarter ended June 30, 2022. The Earnings Release is included as Exhibit 99.1 to this report.

The information contained in this Item 2.02, including Exhibit 99.1 attached hereto, is considered to be "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liability under that Section. The information in this Current Report shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended (the "Securities Act") or the Exchange Act, except as shall be expressly set forth by specific reference in such filing or document. The release contains forward-looking statements regarding the Company and includes a cautionary statement identifying important factors that could cause actual results to differ materially from those anticipated.

Item 7.01 Regulation FD Disclosure.

In connection with the conference call announced in the Earnings Release, on August 4, 2022, the Company made available the Company Information Presentation relating to its financial results for the quarter ended June 30, 2022. The Company Information Presentation may be accessed within the investor relations section of the Company's website, https://www.organon.com. A copy of the Company Information Presentation is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

The information in this Item 7.01, including Exhibit 99.2 attached hereto, is considered to be "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to liability under that Section. The information in this Current Report shall not be incorporated by reference into any filing or other document pursuant to the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing or document. The Company Information Presentation contains forward-looking statements regarding the Company and includes a cautionary statement identifying important factors that could cause actual results to differ materially from those anticipated.

Item 9.01 Financial Statements and Exhibits.






(d) Exhibits.




    Exhibit No.   Description
       99.1         Press Release, dated August 4, 2022, relating to results of
                  operations and financial condition.
       99.2         Company Information Presentation.
        104       The cover page of this Current Report on Form 8-K, formatted in
                  Inline XBRL.

© Edgar Online, source Glimpses